Pharmacogenetics: Clinical Trials

2 trials for Pharmacogenetics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Pharmacogenetics: new trials by email Literature Review of Pharmacogenetics trials Research Report on Pharmacogenetics

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naproxen Pharmacogenetic Study (Project 1, Aim 2)
Naproxen tablet - Pharmacogenetics
Phase 4UnknownUniversity of Washington302016-01-122020-06-29
Pharmacogenomics Studies of Antidepressants
Venlafaxine, Fluoxetine - Major Depressive Disorder, Antidepressive Agents
Phase 4UnknownNational Cheng-Kung University Hospital2002007-03-012010-09-17

Narrower conditions

Depressive Disorder, Major (1)

Broader conditions

Depressive Disorder (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)

Interventions

Fluoxetine (1)  ·  Naproxen (1)  ·  Venlafaxine Hydrochloride (1)

Sponsors

National Cheng-Kung University Hospital (1)  ·  University of Washington (1)

Countries

Taiwan (1)  ·  United States (1)

Top investigators

Kenneth E. Thummel, PhD (1)  ·  Po See Chen, MD (1)

NIH funding

P01GM116691 (1)